Provided by Tiger Fintech (Singapore) Pte. Ltd.

CVS Health

67.36
+1.011.52%
Volume:2.61M
Turnover:174.79M
Market Cap:85.21B
PE:16.07
High:67.77
Open:66.22
Low:66.10
Close:66.35
Loading ...

Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says

MT Newswires Live
·
02 May

Eli Lilly's 'Untapped Volume' in Obesity Drug Counters CVS Setback, Deutsche Bank Says

MT Newswires Live
·
02 May

CVS Health Having 'Nice' Start to 2025 on 'Strong' Q1 Results, Cash Flow Generation, Truist Says

MT Newswires Live
·
02 May

Eli Lilly stock sell-off was 'overrreaction': Analysts

Yahoo Finance
·
02 May

BUZZ-Street View: CVS Health's recovery slow and steady after forecast lift

Reuters
·
02 May

CVS Health Is Maintained at Overweight by Barclays

Dow Jones
·
02 May

CVS Health Corp : Bofa Global Research Raises Price Objective to $85 From $80

THOMSON REUTERS
·
02 May

CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?

Zacks
·
02 May

CVS Health price target raised to $71 from $67 at UBS

TIPRANKS
·
02 May

BUZZ-U.S. STOCKS ON THE MOVE-Airbnb, Cigna, Twilio

Reuters
·
02 May

BUZZ-Street View: Eli Lilly well positioned in weight-loss market despite CVS's decision

Reuters
·
02 May

UBS Adjusts CVS Health Price Target to $71 From $67, Maintains Neutral Rating

MT Newswires Live
·
02 May

Truist Financial Sticks to Their Buy Rating for CVS Health (CVS)

TIPRANKS
·
02 May

The Market Rally Is Strong, This Would Send It Stratospheric. And 5 Other Things to Know Today. -- Barrons.com

Dow Jones
·
02 May

BUZZ-U.S. STOCKS ON THE MOVE-Reddit, Chevron

Reuters
·
02 May

Company News for May 2, 2025

Zacks
·
02 May

Eli Lilly Brushes Off CVS Decision to Drop Zepbound Coverage

MT Newswires Live
·
02 May

Barclays Keeps Their Buy Rating on CVS Health (CVS)

TIPRANKS
·
02 May

CVS Health Corp (CVS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
02 May

PRESS DIGEST - Wall Street Journal - May 2

Reuters
·
02 May